Biotech News
Filter News
Found 535,377 articles
-
Help us identify the leading employers in the life science industry! We want to uncover who leads in key areas like diversity, culture, unique benefits and, of course, who are the 2019 Life Sciences Ideal Employers.
-
The focus will be on discovering drugs that use the body’s natural protein control processes.
-
The team of scientists also found that N-acetyl-cysteine, an antioxidant, decreased liver injury and fibrosis in mice with biliary atresia, resulting in increased survival times.
-
The facility has acted as one of Bristol-Myers Squibb’s primary launch facilities for new drugs. After the deal is closed, Catalent will continue to manufacture Bristol-Myers Squibb’s current product portfolio at that location.
-
Comet has set up shop in Kendall Square with about 10 employees. The company has plans to expand to at least double that amount over the next year as it moves from the preclinical phase to the clinical phase.
-
While Merck’s Keytruda has racked up nearly 20 approvals from the U.S. Food and Drug Administration, there is some investor concern that the company is too dependent on the product for its future.
-
When Becky Fu met Brett Robb at a CRISPR conference four years ago, they were both deeply involved in CRISPR. The two published a paper in March in Nature Microbiology on the subject and on Fu’s findings on the complex mechanisms of the Cpf1 nucleases, a different set of enzymes than the often-us...
-
In North America and across Europe, there is a growing distrust in vaccine safety. France posted the highest mistrust with one-third of people polled.
-
Lawsuits against the FDA are fairly common. However, winning the lawsuit will be a tough road for Catalyst, as other pharma companies that challenged the regulatory agency learned.
-
The drug showed a statistically significant and clinically meaningful improvement in overall abdominal symptoms compared to placebo for all primary and secondary endpoints.
-
Denovo's new asset will target the Alpha2C adrenoceptor.
-
New Studies Suggest That DiA's AI-based Software, LVivo EF, Is Accurate and Efficient in Assessing Ejection Fraction Values Compared to Cardiac MRI and Contrast Echocardiography
6/19/2019
DiA Imaging Analysis, the developers of artificial intelligence (AI) powered ultrasound analysis solutions, has announced today the presentation of two studies assessing the performance and accuracy of the company's LVivo EF AI-based solution that generates fully automated Left Ventricular (LV) Ejection Fraction (EF)
-
CytRx Corporation Highlights Arimoclomol Licensee Orphazyme A/S to Prepare Regulatory Submission in Europe for Niemann-Pick Disease Type C
6/19/2019
CytRx Corporation (OTCQB: CYTR), a biopharmaceutical research and development company specializing principally in oncology, today highlighted that arimoclomol licensee Orphazyme A/S (ORPH.CO) has updated the anticipated timing for submission of its Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) seeking approval for arimoclomol in Niemann-Pick disease Type C (NPC)
-
RADxx Launches New Speakers Bureau
6/19/2019
RAD Women (#RADxx), a networking and mentorship group for women in radiology, informatics, and IT management of radiology systems has today announced a new speakers bureau
-
Grifols to launch plasma-protein-based bleeding-control solutions
6/19/2019
Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), one of the world's three top providers of plasma-derived medicines to treat life-threatening diseases, today announced that the VISTASEAL™ fibrin sealant will be the first product it will introduce with Ethicon Inc. as part of a broad global relationship to provide plasma-protein-based solutions to manage surgical bleeding.
-
Bayer Donation of $45,000 Helped Fund Development of Cook Museum of Natural Science
6/19/2019
The Environmental Science business of Bayer is honored to have contributed $45,000 toward the development of the new Cook Museum of Natural Science that opened on June 7 in Decatur, AL.
-
Clinical Results of Fully Human BCMA CAR-T for the Treatment of Relapsed/Refractory Multiple Myeloma Co-developed by IASO BIO and Innovent Presented at the 2019 ASCO and EHA Annual Meetings
6/19/2019
IASO Biotherapeutics (IASO BIO), one of the top biotechnology innovators, announced their potential best-in-class therapy back-to-back at two of the most prestigious clinical meetings in the worlds of hematology and oncology, the American Society of Clinical Oncology (ASCO) Annual Meeting 2019
-
AAHRPP Accredits Three More Research Organizations Including First in Jordan
6/19/2019
The Association for the Accreditation of Human Research Protection Programs today announced that it has accredited three more research organizations, including the first in Jordan.
-
Food Industry Expert Joins Benson Hill as Chief Operating Officer
6/19/2019
- Benson Hill Biosystems, a crop improvement company unlocking the natural diversity of plants, has named Chris Wilkins, a food industry executive with more than 25 years of industry experience, as Chief Operating Officer.
-
Medison Issues Open Letter to Knight Therapeutics Shareholders Urging Jonathan Goodman to Build Real Business during the Grace Period Knight Received
6/19/2019
Medison Biotech (1995) Ltd. (“Medison”), which together with its affiliates owns more than 10.4 million shares or 7.3% of Knight Therapeutics, Inc. (TSX:GUD) (“Knight” or the “Company”), today issued the following open letter from Medison CEO Meir Jakobsohn on Knight’s continued underperformance and conflicts of interest: